Craig-Hallum Initiates Coverage On MaxCyte With Buy Rating, Announces Price Target of $7
Craig-Hallum Initiates Coverage On MaxCyte With Buy Rating, Announces Price Target of $7
Craig-Hallum 以買入評級啓動對 MaxCyte 的報道,宣佈目標股價爲 7 美元
Craig-Hallum analyst Matt Hewitt initiates coverage on MaxCyte (NASDAQ:MXCT) with a Buy rating and announces Price Target of $7.
Craig-Hallum分析師馬特·休伊特以買入評級開始對MaxCyte(納斯達克股票代碼:MXCT)進行報道,並宣佈目標股價爲7美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。